Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Oral saliva and COVID-19

Outbreak pneumonia announced in Wuhan, China, in December 2019, had its causative factor classified as a new coronavirus (SARS-CoV-2). Since saliva can host several viruses including SARS-CoV-2, the transmission chance of viruses through saliva, particularly those causing respiratory infections, is unavoidable. COVID-19 can be detected through salivary diagnostic testing which has lots of advantages for medical care professionals and patients. It should be noted that not only does saliva offer an ecological niche for the colonization and development of oral microorganisms, but it also prevents the overgrowth of particular pathogens such as viral factors. The aim of this study is to gather all the information about saliva and its association with COVID-19 for the whole health care professionals across the world

Comment in: Oral Oncol. 2020 Sep;108:104926. - PMID 32718820
Year of Publication: 2020
Contained in: Oral oncology Vol. 108 (2020), p. 104821
All journal articles: Search for all articles in this journal
Language: English
Contributors: Baghizadeh Fini, Maryam | Author
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: COVID-19
Dentistry
EC 3.4.15.1
EC 3.4.17.-
Journal Article
Salivary glands
angiotensin converting enzyme 2
Additional Keywords: Aged
Betacoronavirus
Coronavirus Infections
Dental Care
Dentists
Diagnostic Tests, Routine
Female
Humans
Immunity, Innate
Infection Control
Male
Middle Aged
Pandemics
Patient Safety
Peptidyl-Dipeptidase A
Pneumonia, Viral
Practice Patterns, Dentists'
Reverse Transcriptase Polymerase Chain Reaction
Saliva
Salivary Gland Neoplasms
Salivary Glands
Salivary Proteins and Peptides
Sialadenitis
Telemedicine
Xerostomia
ISSN: 1879-0593
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Completed 09.09.2020
Date Revised 09.09.2020
published: Print-Electronic
CommentIn: Oral Oncol. 2020 Sep;108:104926. - PMID 32718820
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PMID:
    32474389
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1016/j.oraloncology.2020.104821
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 04354nma a2200925 c 4500
001 NLM311439578
003 DE-601
005 20200911213905.0
007 cr uuu---uuuuu
008 200601s2020 000 0 eng d
024 7 |a 10.1016/j.oraloncology.2020.104821  |2 doi 
028 5 2 |a pubmed20n1334.xml 
035 |a S1368-8375(20)30257-8 
035 |a (DE-599)NLM32474389 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Baghizadeh Fini, Maryam 
245 1 0 |a Oral saliva and COVID-19  |h Elektronische Ressource 
300 |a Online-Ressource 
500 |a Date Completed 09.09.2020 
500 |a Date Revised 09.09.2020 
500 |a published: Print-Electronic 
500 |a CommentIn: Oral Oncol. 2020 Sep;108:104926. - PMID 32718820 
500 |a Citation Status MEDLINE 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a Copyright © 2020 Elsevier Ltd. All rights reserved. 
520 |a Outbreak pneumonia announced in Wuhan, China, in December 2019, had its causative factor classified as a new coronavirus (SARS-CoV-2). Since saliva can host several viruses including SARS-CoV-2, the transmission chance of viruses through saliva, particularly those causing respiratory infections, is unavoidable. COVID-19 can be detected through salivary diagnostic testing which has lots of advantages for medical care professionals and patients. It should be noted that not only does saliva offer an ecological niche for the colonization and development of oral microorganisms, but it also prevents the overgrowth of particular pathogens such as viral factors. The aim of this study is to gather all the information about saliva and its association with COVID-19 for the whole health care professionals across the world 
611 2 7 |a Journal Article  |2 gnd 
653 2 |a Aged  |6 D000368 
653 2 |a Betacoronavirus  |6 D000073640  |a genetics  |6 Q000235  |a *metabolism  |6 Q000378 
653 2 |a Coronavirus Infections  |6 D018352  |a diagnosis  |6 Q000175  |a *epidemiology  |6 Q000453  |a *transmission  |6 Q000635  |a virology  |6 Q000821 
653 2 |a Dental Care  |6 D003729 
653 2 |a Dentists  |6 D003815  |a psychology  |6 Q000523 
653 2 |a Diagnostic Tests, Routine  |6 D003955  |a methods  |6 Q000379 
653 2 |a Female  |6 D005260 
653 2 |a Humans  |6 D006801 
653 2 |a Immunity, Innate  |6 D007113 
653 2 |a Infection Control  |6 D017053  |a methods  |6 Q000379 
653 2 |a Male  |6 D008297 
653 2 |a Middle Aged  |6 D008875 
653 2 |a Pandemics  |6 D058873 
653 2 |a Patient Safety  |6 D061214 
653 2 |a Peptidyl-Dipeptidase A  |6 D007703  |a metabolism  |6 Q000378 
653 2 |a Pneumonia, Viral  |6 D011024  |a diagnosis  |6 Q000175  |a *epidemiology  |6 Q000453  |a *transmission  |6 Q000635  |a virology  |6 Q000821 
653 2 |a Practice Patterns, Dentists'  |6 D019239 
653 2 |a Reverse Transcriptase Polymerase Chain Reaction  |6 D020133 
653 2 |a Saliva  |6 D012463  |a *immunology  |6 Q000276  |a *virology  |6 Q000821 
653 2 |a Salivary Gland Neoplasms  |6 D012468  |a diagnosis  |6 Q000175 
653 2 |a Salivary Glands  |6 D012469  |a metabolism  |6 Q000378  |a virology  |6 Q000821 
653 2 |a Salivary Proteins and Peptides  |6 D012471  |a immunology  |6 Q000276 
653 2 |a Sialadenitis  |6 D012793  |a *diagnosis  |6 Q000175  |a virology  |6 Q000821 
653 2 |a Telemedicine  |6 D017216  |a methods  |6 Q000379 
653 2 |a Xerostomia  |6 D014987 
655 7 |a COVID-19  |2 gnd 
655 7 |a Dentistry  |2 gnd 
655 7 |a Saliva  |2 gnd 
655 7 |a Salivary glands  |2 gnd 
655 7 |a Salivary Proteins and Peptides  |2 gnd 
655 7 |a Peptidyl-Dipeptidase A  |2 gnd 
655 7 |a EC 3.4.15.1  |2 gnd 
655 7 |a angiotensin converting enzyme 2  |2 gnd 
655 7 |a EC 3.4.17.-  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 |5 DE-601 
689 1 0 |a COVID-19 
689 1 1 |a Dentistry 
689 1 2 |a Saliva 
689 1 3 |a Salivary glands 
689 1 |5 DE-601 
689 2 0 |a Salivary Proteins and Peptides 
689 2 1 |a Peptidyl-Dipeptidase A 
689 2 2 |A r  |a EC 3.4.15.1 
689 2 3 |a angiotensin converting enzyme 2 
689 2 4 |A r  |a EC 3.4.17.- 
689 2 |5 DE-601 
773 0 8 |i in  |t Oral oncology  |g Vol. 108 (2020), p. 104821  |q 108<104821  |w (DE-601)NLM091477565  |x 1879-0593 
856 4 1 |u http://dx.doi.org/10.1016/j.oraloncology.2020.104821  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |d 108  |j 2020  |b 30  |c 09  |h 104821